Design Therapeutics
DSGN
DSGN
63 hedge funds and large institutions have $614M invested in Design Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 3 closing their positions.
Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
30
Reduced
16
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$50.9M |
| 2 |
ACA
2
Avoro Capital Advisors
New York
|
$35.9M |
| 3 |
3
Barclays
London,
United Kingdom
|
$3.66M |
| 4 |
EC
4
EcoR1 Capital
San Francisco,
California
|
$38.3M |
| 5 |
5
Janus Henderson Group
London,
United Kingdom
|
$18.1M |
